Metabolic profile in women with polycystic ovary syndrome across adult life

Metabolism: Clinical and Experimental

Volumn 65, Issue 5, 2016, Pages 776-782

  Echiburú, Bárbara ^a   Crisosto, Nicolás ^a   Maliqueo, Manuel ^a   Pérez Bravo, Francisco ^a   De Guevara, Amanda Ladron ^a   Hernández, Paola ^a   Cavada, Gabriel ^b   Rivas, Catalina ^a   Clavel, Andrés ^a   Sir Petermann, Teresa ^a  

^a UNIVERSITY OF CHILE   (Chile)

^b UNIVERSITY OF CHILE   (Chile)

Author keywords

B cell failure; Insulin resistance; Metabolic syndrome; Perimenopause; Polycystic ovary syndrome

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; STEROID; INSULIN;

ADULT; ANTHROPOMETRIC PARAMETERS; ARTICLE; BLOOD PRESSURE MEASUREMENT; BODY MASS; CHOLESTEROL BLOOD LEVEL; CLIMACTERIUM; CLINICAL ASSESSMENT TOOL; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIET RESTRICTION; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; INSULIN RELEASE; INSULIN SENSITIVITY; LIPID ACCUMULATION PRODUCT INDEX; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MENOPAUSAL SYNDROME; METABOLIC PARAMETERS; METABOLIC SYNDROME X; OBESITY; ORAL GLUCOSE TOLERANCE TEST; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; STEROID BLOOD LEVEL; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE; ADOLESCENT; AGING; BLOOD; BLOOD PRESSURE; CHILE; COHORT ANALYSIS; DISEASE COURSE; FOLLOW UP; INSULIN RESISTANCE; METABOLISM; MIDDLE AGED; PANCREAS ISLET BETA CELL; PATHOPHYSIOLOGY; PREVALENCE; RISK; SECRETION (PROCESS); YOUNG ADULT;

ADIPOSITY; ADOLESCENT; ADULT; AGING; BLOOD PRESSURE; BODY MASS INDEX; CHILE; COHORT STUDIES; CROSS-SECTIONAL STUDIES; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; INSULIN; INSULIN RESISTANCE; INSULIN-SECRETING CELLS; METABOLIC SYNDROME X; MIDDLE AGED; POLYCYSTIC OVARY SYNDROME; PREVALENCE; RISK; WAIST CIRCUMFERENCE; YOUNG ADULT;

EID: 84960470164     PISSN: 00260495     EISSN: 15328600     Source Type: Journal    
DOI: 10.1016/j.metabol.2016.01.006     Document Type: Article

References (20)

1. W.A. March, V.M. Moore, K.J. Willson, D.I. Phillips, R.J. Norman, and M.J. Davies The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria Hum Reprod 25 2010 544 551
2. N.K. Stepto, S. Cassar, A.E. Joham, S.K. Hutchison, C.L. Harrison, R.F. Goldstein, and et al. Women with polycystic ovary syndrome have intrinsic insulin resistance on euglycaemic-hyperinsulaemic clamp Hum Reprod 28 2013 777 784
3. A. Dunaif, K.R. Segal, W. Futterweit, and A. Dobrjansky Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome Diabetes 38 1989 1165 1174
4. L.J. Moran, M.L. Misso, R.A. Wild, and R.J. Norman Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: a systematic review and meta-analysis Hum Reprod Update 16 2010 347 363
5. A. Ladron de Guevara, C. Fux-Otta, N. Crisosto, P. Szafryk de Mereshian, B. Echiburu, G. Iraci, and et al. Metabolic profile of the different phenotypes of polycystic ovary syndrome in two Latin American populations Fertil Steril 101 2014 1732 1739.e1-2
6. J.K. Pai, and J.E. Manson Acceleration of cardiovascular risk during the late menopausal transition Menopause 20 2013 1 2
7. F. Lizcano, and G. Guzman Estrogen deficiency and the origin of obesity during menopause BioMed Res Int 2014 2014 757461
8. R. Alemzadeh, J. Kichler, and M. Calhoun Spectrum of metabolic dysfunction in relationship with hyperandrogenemia in obese adolescent girls with polycystic ovary syndrome Eur J Endocrinol 162 2010 1093 1099
9. J. Puurunen, T. Piltonen, L. Morin-Papunen, A. Perheentupa, I. Järvelä, A. Ruokonen, and et al. Unfavorable hormonal, metabolic, and inflammatory alterations persist after menopause in women with PCOS J Clin Endocrinol Metab 96 2011 1827 1834
10. L.J. Shaw, C.N.B. Merz, R. Azziz, F.Z. Stanczyk, G. Sopko, G.D. Braunstein, and et al. Postmenopausal women with a history of irregular menses and elevated androgen measurements at high risk for worsening cardiovascular event-free survival: results from the National Institutes of Health - National Heart, Lung, and Blood Institute sponsored women's ischemia syndrome evaluation J Clin Endocr Metab 93 2008 1276 1284
11. A.J. Polotsky, A.A. Allshouse, S.L. Crawford, S.D. Harlow, N. Khalil, R. Kazlauskaite, and et al. Hyperandrogenic oligomenorrhea and metabolic risks across menopausal transition J Clin Endocrinol Metab 99 2014 2120 2127
12. A.L. de Guevara, N. Crisosto, B. Echiburu, J. Preisler, N. Vantman, J. Bollmann, and et al. Evaluation of ovarian function in 35-40-year-old women with polycystic ovary syndrome Eur J Obstet Gynecol Reprod Biol 170 2013 165 170
13. R. Newson Review of generalized linear models and extensions by Hardin and Hilbe Stata J 1 2001 98 100
14. D. Panidis, K. Tziomalos, D. Macut, E.A. Kandaraki, E.A. Tsourdi, E. Papadakis, and et al. Age- and body mass index-related differences in the prevalence of metabolic syndrome in women with polycystic ovary syndrome Gynecol Endocrinol 29 2013 926 930
15. F. Ramezani Tehrani, S. Minooee, and F. Azizi Comparison of various adiposity indexes in women with polycystic ovary syndrome and normo-ovulatory non-hirsute women: a population-based study Eur J Endocrinol 171 2014 199 207
16. M. Maliqueo, I. Atwater, R. Lahsen, F. Pérez-Bravo, B. Angel, and T. Sir-Petermann Proinsulin serum concentrations in women with polycystic ovary syndrome: a marker of beta-cell dysfunction? Hum Reprod 18 2003 2683 2688
17. J.O. Ebbert, and M.D. Jensen Fat depots, free fatty acids, and dyslipidemia Nutrients 5 2013 498 508
18. A.M. Chang, and J.B. Halter Aging and insulin secretion Am J Physiol Endocrinol Metab 284 2003 E7 12
19. M.A. Maturana, V. Breda, F. Lhullier, and P.M. Spritzer Relationship between endogenous testosterone and cardiovascular risk in early postmenopausal women Metabolism 57 2008 961 965
20. D. Shah, and S. Bansal Polycystic ovaries - beyond menopause Climacteric 17 2014 109 115